Alseres Pharmaceuticals, Inc. · Hopkinton, MA United States (Pink Sheets: ALSE)
| 239 South St. | Phone: 508-497-2360 |
| Hopkinton, MA | Fax: 508-497-9964 |
| 01748 | |
| United States | 
Map This Company |
Alseres Pharmaceuticals, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Unlike most people, the folks at Alseres Pharmaceuticals (formerly Boston Life Sciences) want to get on your nerves. The biotechnology company is developing therapies and diagnostics related to nervous system conditions, such as spinal cord injury, Parkinson's disease, and attention deficit hyperactivity disorder (ADHD). Its lead candidate is Altropane, a molecular imaging agent for diagnosing Parkinson's disease and ADHD. Another candidate, Cethrin, aims to repair nerve damage caused by spinal cord injury; Alseres licensed Cethrin from Canadian firm BioAxone Therapeutic in 2006.
Alseres Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - Pink Sheets: ALSE Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 3 |
Executives
18 executives listed for Alseres Pharmaceuticals, Inc.'s Hopkinton, MA location.
| Chairman and CEO | Peter Savas | |
|---|---|---|
| EVP Finance and Administration, CFO, and In-House Counsel | Kenneth Rice | |
| SVP Drug Development | Susan Flint |